Apollon Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,734
Closed -$207K 901
2022
Q4
$207K Buy
+1,734
New +$207K 0.01% 776